Age management medicine

Last updated

Longevity medicine is a set of preventive healthcare practices that rely on biomarkers of aging, such as aging clocks, to keep the patient's biological and psychological age as near to peak performance as feasible throughout life. [1] [2] Biogerontology and precision medicine are some of the related fields. [1] As of early 2020s it is a "fast developing field", according to an article in a Lancet specialty journal. [1]

In the first decade of the 21st century, what was called "age management medicine" was considered a field of alternative medicine, [3] and, as of 2007, was not recognized by the American Medical Association. [4] Other names at this time included "antiaging medicine" and "regenerative medicine". [5] Age management medicine is controversial. [4] The field is underregulated and supported by insufficient scientific evidence. People who practice it open themselves up to legal liability on grounds of negligence–malpractice, warranty issues, and product liability. [6] The use of growth hormone has been frequently recommended; however, such use is associated with cancer. [5] Age management medicine is often promoted by anti-aging practitioners specializing in nutritional supplements and hormone-replacement, a practice that may lead to harmful side-effects. [7]

See also

Related Research Articles

<span class="mw-page-title-main">Cancer</span> Group of diseases involving abnormal cell growth and spread

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. While these symptoms may indicate cancer, they can also have other causes. Over 100 types of cancers affect humans.

<span class="mw-page-title-main">Growth hormone</span> Peptide hormone, that stimulates growth

Growth hormone (GH) or somatotropin, also known as human growth hormone in its human form, is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. GH also stimulates production of Insulin-like growth factor 1 (IGF-1) and increases the concentration of glucose and free fatty acids. It is a type of mitogen which is specific only to the receptors on certain types of cells. GH is a 191-amino acid, single-chain polypeptide that is synthesized, stored and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.

Life extension is the concept of extending the human lifespan, either modestly through improvements in medicine or dramatically by increasing the maximum lifespan beyond its generally-settled limit of 125 years. Several researchers in the area, along with "life extensionists", "immortalists", or "longevists", postulate that future breakthroughs in tissue rejuvenation, stem cells, regenerative medicine, molecular repair, gene therapy, pharmaceuticals, and organ replacement will eventually enable humans to have indefinite lifespans through complete rejuvenation to a healthy youthful condition (agerasia). The ethical ramifications, if life extension becomes a possibility, are debated by bioethicists.

<span class="mw-page-title-main">Gerontology</span> Study of the social, psychological and biological aspects of aging

Gerontology is the study of the social, cultural, psychological, cognitive, and biological aspects of aging. The word was coined by Ilya Ilyich Mechnikov in 1903, from the Greek γέρων (gérōn), meaning "old man", and -λογία (-logía), meaning "study of". The field is distinguished from geriatrics, which is the branch of medicine that specializes in the treatment of existing disease in older adults. Gerontologists include researchers and practitioners in the fields of biology, nursing, medicine, criminology, dentistry, social work, physical and occupational therapy, psychology, psychiatry, sociology, economics, political science, architecture, geography, pharmacy, public health, housing, and anthropology.

Controversies regarding the use of human growth hormone (HGH) as treatment method have centered on the claims, products, and businesses related to the use of growth hormone as an anti-aging therapy. Most of these controversies fall into two categories:

  1. Claims of exaggerated, misleading, or unfounded assertions that growth hormone treatment safely and effectively slows or reverses the effects of aging.
  2. The sale of products that fraudulently or misleadingly purport to be growth hormone or to increase the user's own secretion of natural human growth hormone to a beneficial degree.

Hypogonadism means diminished functional activity of the gonads—the testicles or the ovaries—that may result in diminished production of sex hormones. Low androgen levels are referred to as hypoandrogenism and low estrogen as hypoestrogenism. These are responsible for the observed signs and symptoms in both males and females.

<span class="mw-page-title-main">Pituitary adenoma</span> Human disease

Pituitary adenomas are tumors that occur in the pituitary gland. Most pituitary tumors are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.

<span class="mw-page-title-main">Aromatase inhibitor</span> Class of drugs

Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. They may also be used for chemoprevention in women at high risk for breast cancer.

<span class="mw-page-title-main">Letrozole</span> Breast cancer drug

Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer.

The American Academy of Anti-Aging Medicine (A4M) is a United States 501(c)(3) nonprofit organization that promotes the field of anti-aging medicine, and the organization trains and certifies physicians in this specialty. As of 2011, approximately 26,000 practitioners had been given A4M certificates. The field of anti-aging medicine is not recognized by established medical organizations, such as the American Board of Medical Specialties (ABMS) and the American Medical Association (AMA). The academy's activities include lobbying and public relations. The A4M was founded in 1993 by osteopathic physicians Robert M. Goldman and Ronald Klatz, and as of 2013 claimed 26,000 members from 120 countries.

Androgen replacement therapy (ART), often referred to as testosterone replacement therapy (TRT), is a form of hormone therapy in which androgens, often testosterone, are supplemented or replaced. It typically involves the administration of testosterone through injections, skin creams, patches, gels, pills, or subcutaneous pellets. ART is often prescribed to counter the effects of male hypogonadism.

<span class="mw-page-title-main">Laron syndrome</span> Medical condition

Laron syndrome (LS), also known as growth hormone insensitivity or growth hormone receptor deficiency (GHRD), is an autosomal recessive disorder characterized by a lack of insulin-like growth factor 1 production in response to growth hormone. It is usually caused by inherited growth hormone receptor (GHR) mutations.

Thomas Perls is the founding director of the New England Centenarian Study, the longest-running largest study of centenarians and their family members in the world. The Study is worldwide in scope but most of the participants come from the United States and Canada and is funded by three National Institute on Aging grants: The Integrative Longevity Omics Study, Centenarian Project of the Longevity Consortium and the Long Life Family Study. The study is also funded, with great appreciation, by the William M. Wood Foundation and the Paulette and Marty Samowitz Foundation. Born in Palo Alto, California, Perls later moved to Colorado and now lives in Boston. He received his B.A. from Pitzer College in 1982, his M.D. from the University of Rochester School of Medicine and Dentistry in 1986, and his M.P.H. from Harvard University in 1993. Perls is Professor of medicine at Boston University School of Medicine and attending physician in geriatrics at Boston Medical Center. He is the author of over 160 peer-reviewed articles primarily in biodemography and genetics of exceptional human longevity and anti-aging quackery.

Feminizing hormone therapy, also known as transfeminine hormone therapy, is hormone therapy and sex reassignment therapy to change the secondary sex characteristics of transgender people from masculine or androgynous to feminine. It is a common type of transgender hormone therapy and is used to treat transgender women and non-binary transfeminine individuals. Some, in particular intersex people but also some non-transgender people, take this form of therapy according to their personal needs and preferences.

Étienne-Émile Baulieu is a French biochemist and endocrinologist who is best known for his research in the field of steroid hormones and their role in reproduction and aging.

<span class="mw-page-title-main">Adrenal gland disorder</span> Medical condition

Adrenal gland disorders are conditions that interfere with the normal functioning of the adrenal glands. Your body produces too much or too little of one or more hormones when you have an adrenal gland dysfunction. The type of issue you have and the degree to which it affects your body's hormone levels determine the symptoms.

The anti-aging movement is a social movement devoted to eliminating or reversing aging, or reducing the effects of it. A substantial portion of the attention of the movement is on the possibilities for life extension, but there is also interest in techniques such as cosmetic surgery which ameliorate the effects of aging rather than delay or defeat it.

Kent Holtorf is an American physician and entrepreneur practicing in Los Angeles, California. He is a board examiner of the American Board of Anti-Aging Medicine (ABAAM), which is not recognized by established medical organizations. He is the founder and medical director of Holtorf Medical Group, a practice with five centers that offer treatment for conditions including fibromyalgia, adrenal fatigue, complex endocrine dysfunction, hypothyroidism, age management, chronic fatigue syndrome, low libido, chronic Lyme disease, migraines, PMS, perimenopause and menopause. His practice focuses on alternative therapies that are not recognised as effective. He has been criticized in the media for his controversial views on topics like bioidentical hormone replacement therapy and vaccines.

<span class="mw-page-title-main">Anamorelin</span> Chemical compound

Anamorelin (INN), also known as anamorelin hydrochloride, is a non-peptide, orally-active, centrally-penetrant, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) with appetite-enhancing and anabolic effects which is under development by Helsinn Healthcare SA for the treatment of cancer cachexia and anorexia.

<span class="mw-page-title-main">Andrew J Scott</span> Economist, author and professor at the London Business School

Andrew John Scott is a British economist, currently Professor of Economics at London Business School, known for his work on longevity and macroeconomics. Previously he was a lecturer at Oxford University, a visiting professor at Harvard University and a researcher at the London School of Economics.

References

  1. 1 2 3 Bischof, Evelyne; Scheibye-Knudsen, Morten; Siow, Richard; Moskalev, Alexey (2021-04-01). "Longevity medicine: upskilling the physicians of tomorrow". The Lancet Healthy Longevity. 2 (4): e187–e188. doi: 10.1016/S2666-7568(21)00024-6 . ISSN   2666-7568. PMID   36098117. S2CID   233535190.
  2. Holl, Brenna (2021-11-28). "These Are the Core Concepts of Longevity Medicine". Well+Good. Retrieved 2022-01-11.
  3. Walker, Richard F (2007). "Challenges facing age-management/longevity medicine". Clinical Interventions in Aging. 2 (2): 175–177. PMC   2684514 . PMID   18044133.
  4. 1 2 "'Age management' is a controversial new medical focus". CNN. May 9, 2007.
  5. 1 2 Russell, Sabin; Writer, Chronicle Medical (8 June 2006). "Cancer took life of noted user of growth hormone". SFGate.
  6. Reisman, Neal R. (1 July 2004). "Anti-Aging Medicine: The Legal Issues: Legal Issues Associated With the Current and Future Practice of Anti-Aging Medicine". The Journals of Gerontology: Series A. 59 (7): B674–B681. doi: 10.1093/gerona/59.7.B674 . PMID   15304531.
  7. "The Risks of Anti-aging Medicine". CNN. December 14, 2016.